HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Lifted by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 8.1% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,547,402 shares of the company’s stock after buying an additional 115,841 shares during the period. Dimensional Fund Advisors LP owned 1.78% of HealthEquity worth $133,377,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Massachusetts Financial Services Co. MA increased its position in HealthEquity by 20.8% in the second quarter. Massachusetts Financial Services Co. MA now owns 451,259 shares of the company’s stock worth $38,899,000 after buying an additional 77,686 shares during the period. Diversify Wealth Management LLC bought a new position in shares of HealthEquity during the second quarter worth about $8,182,000. Envestnet Asset Management Inc. increased its holdings in shares of HealthEquity by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 115,614 shares of the company’s stock worth $9,966,000 after acquiring an additional 7,645 shares during the period. Oppenheimer Asset Management Inc. lifted its position in HealthEquity by 29.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock valued at $5,535,000 after purchasing an additional 14,573 shares during the last quarter. Finally, AGF Management Ltd. boosted its stake in HealthEquity by 7.3% during the 2nd quarter. AGF Management Ltd. now owns 29,245 shares of the company’s stock valued at $2,521,000 after purchasing an additional 1,985 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $79.53 on Friday. The company has a 50-day moving average of $76.17 and a 200-day moving average of $79.32. The firm has a market cap of $6.92 billion, a price-to-earnings ratio of 86.45, a price-to-earnings-growth ratio of 1.19 and a beta of 0.52. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a twelve month low of $61.81 and a twelve month high of $88.26.

Insider Buying and Selling

In other HealthEquity news, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $82.83, for a total value of $2,677,562.58. Following the transaction, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, CEO Jon Kessler sold 32,326 shares of HealthEquity stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $82.83, for a total value of $2,677,562.58. Following the transaction, the chief executive officer now owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 75,031 shares of company stock worth $6,103,625. Corporate insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the topic of several analyst reports. Barrington Research restated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research note on Friday. JMP Securities restated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. KeyCorp boosted their price target on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 5th. Deutsche Bank Aktiengesellschaft raised their price target on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, Wells Fargo & Company upped their price objective on shares of HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a report on Thursday, June 20th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $103.83.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.